Literature DB >> 3902645

Inactivation of key factors of the plasma proteinase cascade systems by Bacteroides gingivalis.

T Nilsson, J Carlsson, G Sundqvist.   

Abstract

The effect of Bacteroides gingivalis W83 on various key components of the human plasma proteinase cascade systems was studied. When purified C1-inhibitor was incubated with the bacterium, the inhibitor was rapidly inactivated by limited proteolytic cleavage. In citrated whole plasma, C1-inhibitor, antithrombin, plasminogen, prekallikrein, prothrombinase complex, the clotting factor X, and most of the alpha 2-antiplasmin were functionally eliminated after 30 min of incubation with the bacterium. Fibrinogen disappeared from the plasma almost immediately upon mixing with the bacterial suspension. In contrast, there was no appreciable decrease in the bulk of other plasma proteins, such as various transport proteins (albumin, prealbumin, transferrin) and immunoglobulins, during 4 h of incubation with the bacterium. Most of the observed effects can be assigned to the proteolytic activity of the bacterium itself, since there was little evidence for generation of intrinsic plasma proteinase activity, despite the loss of proteinase inhibitory activities. B. gingivalis W83 thus seems to be equipped with proteolytic enzyme systems which selectively recognize and rapidly inactivate the most important proteinase inhibitors and proenzymes present in human plasma. This bacterium therefore seems to be able to efficiently paralyze the host's various defenses against invading microorganisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902645      PMCID: PMC261976          DOI: 10.1128/iai.50.2.467-471.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Hemin and vitamin K compounds as required factors for the cultivation of certain strains of Bacteroides melaninogenicus.

Authors:  R J GIBBONS; J B MACDONALD
Journal:  J Bacteriol       Date:  1960-08       Impact factor: 3.490

2.  Amidolytic activity in normal human plasma assessed with chromogenic substrates.

Authors:  B Lämmle; R Eichlisberger; G A Marbet; F Duckert
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

3.  The nature of clotting and fibrinolytic activities of Bacteroids melaninogenicus.

Authors:  Z Wegrzynowicz; H J Ko; G Pulverer; J Jeljaszewicz
Journal:  Zentralbl Bakteriol Orig A       Date:  1978-01

4.  Agarose gel electrophoresis.

Authors:  J O Jeppsson; C B Laurell; B Franzén
Journal:  Clin Chem       Date:  1979-04       Impact factor: 8.327

Review 5.  Human plasma proteinase inhibitors.

Authors:  J Travis; G S Salvesen
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  A new simple method for determination of C1-esterase inhibitor activity in plasma.

Authors:  B Wiman; T Nilsson
Journal:  Clin Chim Acta       Date:  1983-03-14       Impact factor: 3.786

7.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

8.  Purification and characterization of human C1-esterase inhibitor.

Authors:  T Nilsson; B Wiman
Journal:  Biochim Biophys Acta       Date:  1982-07-26

9.  Structural and circular-dichroism studies on the interaction between human C1-esterase inhibitor and C1s.

Authors:  T Nilsson; I Sjöholm; B Wiman
Journal:  Biochem J       Date:  1983-09-01       Impact factor: 3.857

10.  Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens.

Authors:  M Kilian
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  21 in total

1.  Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50.

Authors:  Minnie Rangarajan; Ahmed Hashim; Joseph Aduse-Opoku; Nikolay Paramonov; Elizabeth F Hounsell; Michael A Curtis
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

2.  Purification and characterization of alkaline phosphatase of Bacteroides gingivalis 381.

Authors:  Y Yamashita; K Toyoshima; M Yamazaki; N Hanada; T Takehara
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Enrichment of subgingival microflora on human serum leading to accumulation of Bacteroides species, Peptostreptococci and Fusobacteria.

Authors:  P F ter Steeg; J S Van der Hoeven; M H de Jong; P J van Munster; M J Jansen
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

4.  Purification and characterization of a protease from Bacteroides gingivalis 381.

Authors:  H Tsutsui; T Kinouchi; Y Wakano; Y Ohnishi
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

Review 5.  Aspects of C1-inhibitor biochemistry and pathophysiology.

Authors:  T K Nilsson
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

Review 6.  Biology of asaccharolytic black-pigmented Bacteroides species.

Authors:  D Mayrand; S C Holt
Journal:  Microbiol Rev       Date:  1988-03

7.  Cleavage of IgG1 and IgG3 by gingipain K from Porphyromonas gingivalis may compromise host defense in progressive periodontitis.

Authors:  Bjarne Vincents; Arndt Guentsch; Dominika Kostolowska; Ulrich von Pawel-Rammingen; Sigrun Eick; Jan Potempa; Magnus Abrahamson
Journal:  FASEB J       Date:  2011-07-18       Impact factor: 5.191

8.  Bacteroides gingivalis vesicles bind to and aggregate Actinomyces viscosus.

Authors:  R P Ellen; D A Grove
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Effect of free and vesicle-bound cysteine proteinases of Porphyromonas gingivalis on plasma clot formation: implications for bleeding tendency at periodontitis sites.

Authors:  T Imamura; J Potempa; R N Pike; J N Moore; M H Barton; J Travis
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.